Patent ID: 7144906
Filing Date: 2006-12-05
Classification: A61K,A61P,C07D

Abstract:
1. A therapeutic pharmaceutical composition for hyperlipidemia, comprising as an active ingredient a heterocyclic compound of the formula [1], or a pharmaceutically acceptable salt thereof: wherein: R Het is an oxazole which is optionally substituted by alkyl or trihaloalkyl; D is alkylene, alkenylene, or alkynylene, and E is a group of the formula [3]: wherein Y is oxygen or sulfur; R 3 is hydrogen or alkyl; p is an integer of 0-2; Z is carboxy, alkoxycarbonyl, hydroxymethyl, carbamoyl, N-hydroxycarbamoyl, N-alkylcarbamoyl, N,N′-dialkylcarbamoyl, cyano, 1H-5-tetrazolyl, 1-alkyl-5-tetrazolyl, or 2-alkyl-5-tetrazolyl; and a pharmaceutically acceptable carrier.